Cradle Genomics logo — Knowledge for Life

Cradle Genomics

Knowledge for Life

Founded 2018 United States San Diego, United States 4 employees Corporate Round Total: $23.10M Biotechnology

General Information

Company Name Cradle Genomics
Founded Year 2018
Location United States San Diego, United States +1
Employees 4
Industries Biotechnology
Funding Stage Corporate Round
Social

Get notified when Cradle Genomics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Cradle Genomics

Cradle Genomics is a biotechnology startup with a mission to provide knowledge that positively impacts every pregnancy. The company aims to transform non-invasive prenatal testing (NIPT) by offering comprehensive fetal genetic analysis and pregnancy health screening solutions during the earliest stages of pregnancy. Founded in 2018 and headquartered in San Diego, Cradle Genomics has recently received a $6.00MCorporate Round investment from Pacific West Bank on 19 February 2020. Cradle Genomics distinguishes itself by swiftly collecting and analyzing fetal cells during a first trimester visit, with no risk to the mother or developing fetus. This innovative approach reflects the company's dedication to improving patient care and ensuring global access to top-tier prenatal solutions. The startup's commitment to advancing prenatal care aligns with the growing demand for cutting-edge technologies in the healthcare industry. By focusing on early-stage fetal genetic analysis and pregnancy health screening, Cradle Genomics is poised to make a significant impact on the biotechnology and healthcare sectors. For more information, interested parties can reach out to Cradle Genomics at [email protected].

Taxonomy: Non-Invasive Prenatal Testing, Clinical Genomics, Next Generation Sequencing, Fetal Cell Collection, Chromosomal Abnormalities, Monogenic Disorders, Reproductive Health, Prenatal Solutions, Genetic Analysis, Pregnancy Health Screening, Early Pregnancy Care, San Diego Headquarters, Detroit R&D Operations, Prenatal Care, Fetal Genetic Analysis

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Corporate Round •••••• 1 •••• •••• 19 Feb 2020
Series A •••••• 5
Investor Investor Investor
•••• ••••
16 Jul 2019

Cradle Genomics Alternatives & Competitors

Cradle Genomics vs

Protecting the Promise of Life with At-Home Fetal Monitoring

Grant
Health Care
Cradle Genomics vs

Comprehensive care for all your women's health needs, from fertility and pregnancy to advanced gynec...

11-50 employees
Health Care
Cradle Genomics vs

Bringing accessible, non-invasive prenatal genetic testing to every woman through pioneering whole f...

Series B
Biotechnology, Health Care

FAQ About Cradle Genomics

Knowledge for Life
Cradle Genomics was founded in 2018.
Cradle Genomics is headquartered in San Diego, United States.
Cradle Genomics operates in the following industries: Biotechnology.
Cradle Genomics has approximately 4 employees.
Cradle Genomics has completed 2 funding rounds, raising a total of $23.10M. The latest funding stage is Corporate Round.
Top alternatives and competitors to Cradle Genomics include Remotaid, Women’s Obstetrics and Gynecology, CellScape, Bloomlife Inc, Ouma Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cradle Genomics and Remotaid are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Cradle Genomics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy